NCT06237257 - A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2025

Conditions

Locally Advanced Cervical Cancer

Interventions

BIOLOGICAL

SHR-1316

SHR-1316（Adebrelimab Injection）

DRUG

Cisplatin Injection/Carboplatin Injection

RADIATION

External Beam Radiotherapy (EBRT)/Brachytherapy

DRUG

Paclitaxel Injection

Paclitaxel Injection.

Trial Locations (1)

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Shanghai Shengdi Pharmaceutical Co., Ltd

INDUSTRY